Foster Dykema Cabot & CO Inc Moderna, Inc. Transaction History
Foster Dykema Cabot & CO Inc
- $827 Million
- Q3 2023
A detailed history of Foster Dykema Cabot & CO Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Foster Dykema Cabot & CO Inc holds 10 shares of MRNA stock, worth $318. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 10
-0.0%
Holding current value
$318
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
909Shares Held
235MCall Options Held
10.6MPut Options Held
18.6M-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.28 Billion0.05% of portfolio
-
Baillie Gifford & CO38.9MShares$1.24 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$815 Million0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$537 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$230 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.5B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...